ALLG

Allego earns a Neutral rating with two-out-of-five conviction, reflecting a composite score in the low 40s and limited evidence for a directional call. Regulatory performance led the framework in the high 40s, supported by a clean enforcement record and a midrange jurisdiction posture. Fundamentals followed in the mid-40s, where market-cap scale and the cash-runway subscore partly offset contraction and weak profitability. The market pillar landed near 40 because no institutional quote was available, while editorial contribution trailed at roughly 30 amid no recent newsroom or brief activity. The resulting mix supports the Neutral band rather than an Overweight stance, while stretched financial condition prevents the regulatory lead from carrying greater weight.

Licensed fundamentals data show year-over-year revenue contracting by roughly one-fifth. Gross margin registered about 17.3%, leaving limited operating leverage, while operating margin remained negative at approximately 25.1%. The company also recorded a net loss near $109.9 million and negative EBITDA of about $43.1 million, confirming that profitability and financial flexibility remain constrained. A cash-burn ratio near 0.087 and the cash-runway subscore provide some support within fundamentals, but neither offsets the bottom-line loss or the stretched condition. Primary regulatory filings show no dated latest filing in the supplied record, producing a weak cadence subscore despite no enforcement hits or regulatory events during the measured 90-day and 180-day windows. Institutional pricing feeds provide no current quote, and CIN newsroom coverage contains no recent hits.

The clearest forward catalyst sits within the regulatory pillar, already Allego’s strongest contributor. A newly dated primary regulatory filing would directly address the cadence weakness while preserving the benefit of the clean enforcement profile. Consistent filings would also improve visibility into whether revenue contraction, negative margins, and cash consumption are stabilizing, enabling a firmer assessment of the stretched financial position. Market and editorial signals remain secondary until institutional pricing feeds resume and CIN newsroom coverage gains substance. The single most important forward signal to watch is the appearance of a current primary regulatory filing that restores cadence and clarifies operating progress.